Schedule 13D ownership disclosure
CESCA THERAPEUTICS INC.
Security class unavailable · CUSIP: 157131103
Event date: 2016-02-13
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 26,470,588
- Percent of class
- 20.3000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001019687-16-005569
- Form type
- SC 13D
- Filer
- ThermoGenesis Holdings, Inc.
- CIK
- CIK 811212
- Filed
- Mar 25, 2016
- Reporting period
- Feb 13, 2016
- Description
- Schedule 13D beneficial ownership